A three-word message has offered another astonishing glimpse of where brain-computer technology is heading.

“I love you,” a synthetic voice says in a 23-second video posted by Elon Musk’s Neuralink under the caption: “A beautiful surprise”.

The footage shows an unidentified trial participant using Neuralink’s brain implant to communicate the message.

The clip follows a more detailed demonstration Neuralink released in March involving a separate participant identified only as Kenneth.

The footage shows an unidentified trial participant using Neuralink’s brain implant to communicate the message.

Kenneth was diagnosed with motor neurone disease (MND), known as ALS in the US, in 2024 and gradually lost his ability to speak. Neuralink said he became the second participant implanted for its VOICE program in January.

“There we go. I’m talking to you with my mind,” he said during the demonstration.

Neuralink’s VOICE study is examining whether its wireless N1 implant can translate signals associated with intended speech into text or audible words. The device uses tiny electrode threads placed in the brain to record neural activity, which decoding software then attempts to interpret.

Contrary to what some might be thinking when they hear the word “brain chip”, the process is very different from indiscriminately reading somebody’s private thoughts.

Current systems require users to deliberately perform a trained mental action, such as attempting speech, imagining finger movements or thinking about moving a cursor. They cannot simply rummage through memories or broadcast every stray thought that passes through a person’s head.

At least not yet.

Musk has repeatedly predicted that brain implants could eventually allow people to exchange concepts without speaking or typing.

The concept of translating brain patterns to speech is not entirely new, but the recent advancements in artificial intelligence are now bleeding into the space at speed.

University of California, San Francisco (UCSF), researchers first translated brain activity into sentences in 2021. A team from the US’ Stanford University, in California, later reached 62 words per minute with a participant who had MND in 2023. While UCSF developed by generated text, synthetic speech and facial movements through a digital avatar.

Researchers demonstrated real-time decoding of deliberately imagined inner speech in 2025, although accuracy remained inconsistent and the experiments involved only a handful of participants.

Neuralink’s contribution to the frontier is its attempt to turn the laboratory progress into a compact, wireless device people can use regularly.

Mr Musk has described the company’s medical work as “restoring speech”, but his ambitions extend much further. He has repeatedly predicted that brain implants could eventually allow people to exchange concepts without speaking or typing.

“We could actually send the true thought,” he said during a Neuralink presentation in 2020, describing a future form of “conceptual telepathy”.

“We presume it would be consensual because you definitely don’t want just people, you know, sending stuff into your brain without your consent.”

In their current state, Neuralink’s devices remain investigational and have not been approved for commercial sale. Photo: Neuralink

For people living with paralysis, stroke or degenerative disease, the potential is absolutely enormous.

But the technology still carries an unsettling smorgasbord of medical and ethical risks.

Brain implants require surgery, bringing risks including infection, bleeding and seizures. Their electrodes must continue operating as brain tissue changes around them, while batteries, wireless connections and software need to remain reliable for years.

And then you have the obvious data problem.

The Australian Human Rights Commission has warned that information collected by neurotechnology poses a “significant risk to privacy”. Its examination of 30 consumer neurotechnology companies found that 24 had policies potentially allowing them to sell users’ neural data.

That study did not cover Neuralink’s clinical implant, but it highlights why regulations need to arrive before consumer brain interfaces flood the market.

In their current state, Neuralink’s devices remain investigational and have not been approved for commercial sale.

“Neuralink devices are investigational and have not been approved by the FDA or other regulatory authorities,” the company posted under the video.

“This video features voluntary clinical trial participants sharing their personal experiences, which may not reflect all participants or future outcomes.”

Home

Musk’s brain chips make stunning new leap